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Aims: We compared upper trunk anthropometric indices with overall and central obesity
indicators to predict the presence of type 2 diabetes in middle-aged and elderly Korean
individuals.
Methods: This cross-sectional investigation included 4079 rural and urban participants aged
40–80 years. Neck, thoracic, waist (WC), and hip circumferences were measured by a reliable
and standardized method. The neck-to-hip ratio, the thoracic-to-hip ratio (THR), and the
waist-to-hip ratio (WHR) were calculated. A 75-g oral glucose tolerance test was performed.
Type 2 diabetes was defined based on the guidelines of the World Health Organization
(1999).
Results: The receiver operator characteristic curve analysis indicated that THR and WHR
were better than body mass index (BMI) and other anthropometric indices at predicting the
presence of type 2 diabetes. The adjusted odds ratios (OR) across quartiles of THR were
slightly higher than the ORs for WHR, particularly in the highest quartile (odds ratios and
95% CI: 2.11 (1.47–3.04) versus 1.95 (1.37–2.77) in men; 3.40 (2.18–5.31) versus 2.31 (1.48–3.60)
in women). The associations of THR and WHR with type 2 diabetes remained significant,
despite a slight attenuation after a multivariate adjustment for BMI. The joint effect of BMI
and THR on the risk of type 2 diabetes was larger than that of BMI and WHR.
Conclusions: THR may be a novel marker of type 2 diabetes, particularly in women, and its
association with diabetes was independent of BMI and WHR.
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Type 2 diabetes has become a global epidemic health problem
worldwide, and it is closely related to numerous cardiometabolic
complications of obesity [1]. Body mass index (BMI) has been the
most commonly used measure of overall obesity to reflect total
body fat, although the index cannot distinguish between muscle
and fat mass [2]. Many studies have demonstrated that excessive
accumulation of adipose tissue in particular body regions
contributes to metabolic complications [3,4].
Vague [5] first proposed that those who have fat
predominantly accumulated in the upper body rather than
the lower body are more susceptible to metabolic dis-
turbances. For several decades, numerous studies examined
this hazardous body shape phenotype; however, most
emphasized the impact of body fat centralization, measured
by waist circumference (WC) or waist-to-hip ratio (WHR), on
the risk of metabolic complications [6,7]. Freedman and
Rimm demonstrated that fat accumulation in various
regions of the upper trunk had different diabetes correlates
independent of abdominal fat [8]. In recent years, interest
has increased in the cardiometabolic correlates of upper
body subcutaneous (sc) [9,10], intra-thoracic [11,12], and
pericardial fat [13]. Kang et al. found that android fat, a fat
depot located just above the central fat depot, is more
accurate than abdominal visceral adipose tissue (VAT) at
predicting metabolic syndrome [14].
Body girth measurements at multiple regions of the trunk
can provide information on particular local fat accumulation,
whereas girth ratios may reflect the fat distribution pattern
and body shape. Numerous epidemiological studies have
used WHR as a determinant of the fat distribution pattern;
however, WHR, which contains information on abdominal fat
and hip fat, does not reflect the concrete image of fat
distribution. In addition, whether body fat distribution
provides more accurate information on the risk of type 2
diabetes than total body fat remains controversial [15].
Because of the increasing evidence of metabolic correlates
of upper trunk fat, we assess the association of upper trunk
circumferences and their ratios to hip circumference (HC)
with type 2 diabetes and examine whether these anthropo-
metric indices can predict type 2 diabetes more accurately
than overall obesity (assessed by BMI) and central obesity
(assessed by WC and WHR) indicators.
2. Materials and methods
2.1. Participants
The current study was designed as a cross-sectional inves-
tigation as part of the Korean Health and Genome Epidemiol-
ogy Study (KHGES), an ongoing perspective cohort study [16].
A total of 7629 participants aged 10 years or more were
recruited using a two-stage cluster sampling method by
telephone or mail from June 2009 to December 2011 at the
Korea University Ansan Hospital and the Center for Clinical
Epidemiology of Ajou University Hospital. The Ansan cohort
data represent an urban community, and the Ansung cohortdata represent a rural community. In this analysis, we
included only participants aged 40–80 years and excluded
participants who had been diagnosed with diabetes and/or
were receiving medication for hypertension, diabetes, dysli-
pidemia, and who had missing data on body composition
indices, body measurements, blood pressure, fasting plasma
glucose (FPG), 2-h post-load plasma glucose, or smoking and
drinking information. The analysis was performed on 4079
participants (1967 men and 2112 women). This study was
approved by the National Institute of Health Ethics and the
Institutional Review Board of the Korean Health and Genomic
Study, Ajou University. All of the participants gave their
written informed consent.
2.2. Anthropometric indices and body composition
measurements
Body measurements were measured horizontally with a
tapeline to the nearest 1 mm by trained operators following
the standardized operating procedure developed by Jang et al.
[17]. It has been revealed that these measurements have a
high reliability with relative total technical error of measure-
ment were 0.68%–2.18% [17]. Neck circumference (NC) was
measured at the lower margin of the thyroid cartilage while
participants sat on a chair with their heads positioned
horizontally. Thoracic circumference (ThC), WC, and HC
were measured while participants stood erect and breathed
naturally. The tapeline was positioned at the left and right
prominences of the 7th–8th costochondral junctions, and the
ThC value was recorded between inspiration and expiration.
WC and HC were measured at the umbilicus scar and upper
margin of the pubis, respectively. The neck-to-hip circum-
ference (NHR), thoracic-to-hip circumference (THR), and
waist-to-hip circumference (WHR) ratios were defined as
NC, ThC, and WC divided by HC, respectively. Thus, the
upper-trunk-related anthropometric indices were NC, ThC,
NHR, and THR.
Body height and weight were measured using a digital scale
(GL-150; G Tech International Co., Ltd., Uijeongbu). Participants
wore casual clothing. The mandibular plane was parallel to the
floor. BMI was calculated as weight (kg) divided by height
squared (m2). Body fat mass (BFM) was assessed using a
bioelectrical impedance analyzer (BIA) (INBODY 720, Biospace
Korea). In addition, body fat percent (BFP) was calculated by
dividing BFM by body weight.
2.2.1. Definition of type 2 diabetes
The measurements of blood pressure, fasting and 2-h post-
load glucose concentration, and lipid profiles have been
described in detail in a previous study [18]. Type 2 diabetes
was defined as a FPG  126 mg/dl [7.0 mmol/l] and/or a 2-h
post-load plasma glucose 200 mg/dl [11.1 mmol/l], according
to the 1999 World Health Organization diagnostic criteria [19].
2.3. Confounding factors
Participants were classified as current smokers if they smoked
currently, ex-smokers if they had smoked previously but had
quit, and nonsmokers if they had never smoked. The same
classification was applied for alcohol consumption.
Table 1 – Characteristic of study participants.
Men
(n = 1967)
Women
(n = 2112)
p
Study center
Ansan n (%) 885 (45.0) 1067 (50.5)
Ansung n (%) 1082 (55.0) 1045 (49.5)
Age (yrs) 57.9 (8.3) 57.6 (8.3) 0.27
Body height (cm) 166.9 (5.8) 154.4 (5.7) <0.0001
Body weight (kg) 66.4 (9.5) 57.5 (8.1) <0.0001
BMI (kg/m2) 23.8 (2.9) 24.1 (3.1) 0.001
NC (cm) 37.0 (2.2) 32.8 (1.9) <0.0001
ThC (cm) 86.7 (6.1) 79.1 (7.2) <0.0001
WC (cm) 85.6 (7.5) 83.7 (8.3) <0.0001
HC (cm) 91.9 (5.2) 92.3 (5.3) 0.006
NHR 0.40 (0.02) 0.36 (0.02) <0.0001
THR 0.94 (0.04) 0.86 (0.06) <0.0001
WHR 0.93 (0.05) 0.91 (0.07) <0.0001
SBP (mm Hg) 118.6 (15.1) 114.8 (16.5) <0.0001
DBP (mm Hg) 79.2 (9.8) 75.1 (10.1) <0.0001
FPG (mg/dl) 98.2 (16.4) 92.8 (11.4) <0.0001
2 h post-load glucose (mg/dl) 127.0 (51.2) 128.7 (40.8) <0.0001
Total cholesterol (mg/dl) 191.8 (32.9) 202.2 (33.4) <0.0001
Triglycerides (mg/dl) 138.4 (70.2) 120.1 (57.5) <0.0001
HDL cholesterol (mg/dl) 45.3 (12.0) 49.0 (12.6) <0.0001
LDL cholesterol (mg/dl) 118.8 (30.1) 129.2 (29.9) <0.0001
Smoking, n (%)
Non smoker 506 (25.7) 2064 (97.7) <0.0001
Ex-smoker 810 (41.2) 16 (0.8)
Current smoker 651 (33.1) 32 (1.5)
Drinking, n (%)
Non drinker 482 (24.5) 1526 (72.2) <0.0001
Ex-drinker 122 (6.2) 33 (1.6)
Current drinker 1363 (69.3) 553 (26.2)
Diabetes, n (%) 331 (16.8) 225 (10.7) <0.0001
Values are means (SD) or n (%). p values are calculated from t-tests
or chi-square tests for analysis of variance. BMI, body mass index;
NC, neck circumference; WC, waist circumference; HC, hip
circumference; ThC, thoracic circumference; NHR, neck-to-hip
circumference ratio; THR, thoracic-to-hip circumference ratio;
WHR, waist-to-hip circumference ratio; SBP, systolic blood pres-
sure; DBP, diastolic blood pressure; FPG, fasting plasma glucose;
HDL cholesterol, high-density lipoprotein cholesterol; LDL choles-
terol, low-density lipoprotein cholesterol.
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The data were analyzed using R software, version 2.14.1, on a
Windows 7 platform. The significance level was set to 0.05. A
receiver operating characteristic (ROC) curve was used to
estimate the predictive performance of BMI and anthropo-
metric indices and to calculate the optimal cutoff points in
predicting type 2 diabetes. More area under the ROC curve
(AUC) implies more predictive performance. The optimal
cutoff for each determinant of type 2 diabetes was determined
by the Youden index [20]. A univariate logistic regression was
used to assess the association between a one standard
deviation (SD) increase in BMI and all anthropometric indices
and type 2 diabetes. A multiple logistic regression analysis
adjusted for age, habitual smoking, alcohol consumption, and
study center was used to evaluate the risk increase by
quartiles of BMI and all anthropometric indices. We used
the AUC value and the odds ratio (OR) to determine the upper
trunk anthropometric index that was most closely associated
with type 2 diabetes. Further adjustments for overall obesity
(assessed by BMI) and central obesity (assessed by WC and
WHR) indicators were included to assess the independent and
joint effects of the upper trunk anthropometric index in
predicting type 2 diabetes.
3. Results
The characteristics of participants by gender are presented in
Table 1. Compared to the women, the men were heavier and
taller and had a lower BMI, body fat mass, and fat percent.
Additionally, men had larger anthropometric indices and
higher risk of type 2 diabetes than women.
3.1. Association of anthropometric indices with type 2
diabetes and their cutoffs
BMI and all anthropometric indices were associated with type
2 diabetes. The ROC analysis indicated that THC had a stronger
relationship with type 2 diabetes than BMI, NC, or WC (men:
AUC = 0.551 versus 0.533, 0.535, and 0.541; women:
AUC = 0.578 versus 0.559, 0.545, and 0.559). THR and WHR
(men: AUC = 0.577 and 0.564; women: AUC = 0.606 and 0.582)
were stronger markers of type 2 diabetes than BMI and other
anthropometric indices. The optimal cutoff points estimated
by the Youden index for predicting diabetes for THR and WHR
were 0.93 and 0.93 in men and 0.88 and 0.90 in women (Table
2). Each increase in the SD of the THR was associated with a
1.29-fold (1.15–1.45) and a 1.48-fold (1.29–1.70) increase in the
odds ratios of type 2 diabetes in men and women, respectively
( p < 0.0001), whereas those of the WHR were 1.23-fold (1.09–
1.39) and 1.38 (1.20–1.58) in men ( p = 0.001) and women
( p < 0.0001), respectively (Table 2). After adjustments for
potential confounders, including age, habitual smoking,
alcohol consumption, and study center, THR and WHR still
had a stronger association with type 2 diabetes than BMI and
other anthropometric indices. The adjusted ORs for the
second, third, and fourth quartiles of THR were 1.48 (1.02–
2.14), 1.91 (1.33–2.75), and 2.11 (1.47–3.04) in men and were 1.65
(1.05–2.59), 1.61 (1.02–2.56), and 3.40 (2.18–5.31) in women,respectively, whereas those values for WHR were 1.53 (1.07–
2.20), 1.47 (1.02–2.12), and 1.95 (1.37–2.77) in men and 1.60
(1.03–2.49), 1.67 (1.07–2.61), and 2.31 (1.48–3.60) in women,
respectively (Table 3).
3.2. Independent and joint effects of the THR and WHR in
predicting type 2 diabetes
The second objective of this study was to determine whether
THR, the upper-trunk-related anthropometric index that was
most related to type 2 diabetes, was an independent
determinant of type 2 diabetes to overall and central obesity
indicators. Because the data showed that WHR was more
closely associated with type 2 diabetes than WC, a comparison
of the magnitude of the association with type 2 diabetes was
conducted between BMI, WHR, and THR.
The multiple logistic regression analysis showed that the
adjustment for potential confounders and BMI slightly
attenuated the association between THR and WHR with type
Table 2 – Association of BMI and anthropometric indices with type 2 diabetes.
OR (95% CI) AUC (95% CI) Cutoff Se Sp
Men
BMI (kg/m2) 1.12 (1.00–1.26) 0.533 (0.497–0.569) 25.7 0.33 0.76
NC (cm) 1.15 (1.02–1.29) 0.535 (0.499–0.570) 38.6 0.30 0.78
ThC (cm) 1.20 (1.06–1.35) 0.551 (0.516–0.586) 89.1 0.42 0.69
WC (cm) 1.16 (1.03–1.30) 0.541 (0.506–0.576) 88.0 0.45 0.63
NHR 1.18 (1.04–1.33) 0.539 (0.505–0.574) 0.42 0.25 0.83
THR 1.29 (1.15–1.45) 0.577 (0.544–0.610) 0.93 0.74 0.38
WHR 1.23 (1.09–1.39) 0.564 (0.530–0.598) 0.93 0.65 0.47
Women
BMI (kg/m2) 1.23 (1.08–1.40) 0.559 (0.518–0.600) 25.0 0.47 0.66
NC (cm) 1.19 (1.04–1.36) 0.545 (0.540–0.587) 33.3 0.48 0.63
ThC (cm) 1.30 (1.14–1.49) 0.578 (0.539–0.618) 80.5 0.52 0.62
WC (cm) 1.24 (1.08–1.42) 0.559 (0.520–0.599) 83.9 0.57 0.54
NHR 1.22 (1.07–1.40) 0.548 (0.507–0.588) 0.37 0.34 0.75
THR 1.48 (1.29–1.70) 0.606 (0.565–0.646) 0.88 0.50 0.69
WHR 1.38 (1.20–1.58) 0.582 (0.543–0.622) 0.90 0.65 0.49
OR (95% CI), odds ratio (95% confidence interval) for type 2 diabetes with each standard deviation increase in the independent variables,
calculated by univariate analysis; AUC (95% CI), area under the curve values (95% confidence interval) calculated by receiver operating
characteristic curve; cut-off, cut-off point for independent variables in predicting type 2 diabetes determined by Youden index; Se, sensitivity;
Sp, specificity. The two highest OR and AUC values are in bold. For other abbreviations, see Table 1.
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cients between BMI and THR were 0.28 in men and 0.45 in
women, whereas the correlation coefficients between BMI and
WHR were 0.49 in men and 0.44 in women (Supplementary,
Table S2). The adjusted ORs for the THR were higher than
those for the WHR in all models, particularly for women
(Supplementary, Table S1). Furthermore, there was an
increase in the prevalence of type 2 diabetes by tertiles of
THR within each tertile of WHR, particularly in the highest
WHR tertile (Fig. 1). Within each tertile of WHR, the higher
tertiles of THR had a stronger risk of type 2 diabetes, including
plasma fasting and 2-h post-load glucose and triglyceridesTable 3 – Adjusted odds ratios of type 2 diabetes by quartiles 
Quartile 1 Quartile 2 
Men
BMI 1 0.79 (0.56–1.13) 
NC 1 0.85 (0.61–1.21) 
ThC 1 1.03 (0.72–1.47) 
WC 1 1.00 (0.71–1.42) 
NHR 1 1.19 (0.84–1.69) 
THR 1 1.48 (1.02–2.14)*
WHR 1 1.53 (1.07–2.20)*
Women
BMI 1 1.14 (0.75–1.75) 
NC 1 0.90 (0.59–1.37) 
ThC 1 1.11 (0.72–1.71) 
WC 1 1.00 (0.65–1.53) 
NHR 1 1.28 (0.85–1.93) 
THR 1 1.65 (1.05–2.59)*
WHR 1 1.60 (1.03–2.49)*
Data are presented as odds ratio (95% confident interval) adjusted for age
1, 2, 3, and 4 represent the lowest, low medium, high medium, and hig
lowest quartile was the reference category. For other abbreviations, see 
* Significant level: p < 0.05.
** Significant level: p < 0.01.
*** Significant level: p < 0.001.concentrations, than the lower tertiles (Supplementary, Fig.
S1). These results indicate the independent effect of THR on
diabetes.
Supplementary material related to this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.diabres.2013.12.022.
To examine the joint effects of BMI, THR, and WHR in
predicting type 2 diabetes, we stratified participants using
internally calculated cutoffs. The cutoff for BMI (25.7 kg/m2 for
men and 25.0 kg/m2 for women), THR (0.93 for men and 0.88 for
women), and WHR (0.93 for men and 0.90 for women) were
calculated from the distribution of the study sample (Table 2).of BMI and anthropometric indices for men and women.
Quartile 3 Quartile 4
0.86 (0.60–1.22) 1.43 (1.02–2.00)*
1.05 (0.74–1.49) 1.67 (1.19–2.34)**
1.25 (0.88–1.78) 1.71 (1.22–2.40)**
1.21 (0.85–1.72) 1.54 (1.10–2.16)*
1.17 (0.82–1.66) 1.53 (1.09–2.15)*
1.91 (1.33–2.75)*** 2.11 (1.47–3.04)***
1.47 (1.02–2.12)* 1.95 (1.37–2.77)***
1.32 (0.87–2.00) 1.68 (1.13–2.51)*
1.07 (0.72–1.58) 1.70 (1.16–2.49)**
1.53 (1.01–2.32)* 2.15 (1.43–3.25)***
1.48 (0.99–2.20) 1.51 (1.00–2.29)*
0.99 (0.65–1.53) 1.86 (1.25–2.77)**
1.61 (1.02–2.56)* 3.40 (2.18–5.31)***
1.67 (1.07–2.61)* 2.31 (1.48–3.60)***
, habitual smoking, alcohol consumption, and study center. Quartiles
hest quartiles, respectively, of BMI and anthropometric indices. The
Table 1.
Fig. 1 – Prevalence of type 2 diabetes of tertiles of THR across tertiles of WHR. THR, thoracic-to-hip ratio (THR1, THR2, and
THR3 refers to tertiles of THR within each tertile of WHR); WHR, waist-to-hip ratio (WHR 1, WHR 2, and WHR 3 refer to
tertiles of WHR).
Fig. 2 – Joint and independent effects of BMI, WHR, and THR in predicting type 2 diabetes for men and women. The cutoff
point for BMI was 25.7 kg/m2 for men and 25.0 kg/m2 for women (see Table 2); cutoff points for WHR (see Table 2) were 0.93
for men and 0.90 for women; cutoff points for THR (Table 2) were 0.93 for men and 0.88 for women. (H) means high category
of independent variables (e.g., BMI (H) means BMI I 25.7 kg/m2 for men and I25.0 kg/m2 for women); (L) means low
category of independent variable (e.g., BMI (L) means BMI < 25.7 kg/m2 for men and <25.0 kg/m2 for women). The sample
was stratified into 8 categorizes with 7 dummies. The group of subjects with low BMI, low WHR, and low THR was setup as
the reference group. *p < 0.05; **p < 0.01; ***p < 0.001, assessed by multivariable logistic regression analysis adjusted for age,
smoking, drinking, and study center. Bars represent the adjusted odds ratio of type 2 diabetes; numbers are odds ratio (95%
confident interval).
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dummy variables (Fig. 2). The group that did not have high
BMI, high WHR, or high THR was used as the reference
category in the multiple logistic regression analysis adjusted
for potential confounders. As shown in Fig. 2, those who had
only a high BMI or high WHR or high THR did not have a
significantly higher risk of type 2 diabetes than the reference
group for both men and women. The adjusted ORs for
individuals who had high BMI and high THR were 2.35
(1.25–4.43) for men ( p < 0.01) and 3.05 (1.09–8.51) for women
( p < 0.05). The adjusted ORs for individuals with high BMI and
high WHR were 1.30 (0.60–2.83) for men ( p = 0.50) and 1.11
(0.59–2.06) for women ( p = 0.75). Additionally, the risk increase
for individuals with high BMI, high THR, and high WHR (ORs
were 2.27 in men and 3.34 in women) was not remarkably
higher than that of individuals who had only high BMI and
high THR.
4. Discussion
Many previous studies stressed the link between overall
(assessed by BMI) and central (assessed by WC and WHR)
obesity and increased risk of metabolic complications,
including type 2 diabetes [21–24]. Debate continues about
the best anthropometric indices for diabetes. Recent studies
have focused on the cardiometabolic correlates of upper trunk
fat and upper trunk-related anthropometric indices, such as
NC [9,10], and the ‘‘protective’’ effect of hip size [24,25].
However, no studies have compared upper trunk-related
anthropometric indices and indicators of overall and central
obesity for predicting type 2 diabetes. The present study is the
first attempt to compare the effects of upper trunk-related
anthropometric indices and indicators of overall and central
obesity in predicting type 2 diabetes in Korean adults. We
found that (i) THR is the upper-trunk-related anthropometric
index that is most closely related to type 2 diabetes among the
upper-trunk-related anthropometric indices; (ii) THR appears
to be an independent determinant of type 2 diabetes to BMI
and WHR and its effect may be better than that of WHR in
women; and (iii) BMI and THR can predict type 2 diabetes
better than BMI and WHR.
Our findings suggested that the strength of the association
between diabetes and ThC is slightly stronger than that of NC
and WC. Moreover, THR is the strongest marker of type 2
diabetes among all investigated indices, particularly in
women. ThC reflects the size of thoracic cavity and the body
segment where android fat is measured by dual-energy X-ray
absorptiometry [14]. Evidence suggests that android fat
components, such as pericardial, hepatic, and intra-thoracic
fats, are associated with metabolic disturbances independent
of total and abdominal fatness [11–13], and the metabolic
correlates of android fat are stronger than those of VAT [14]. It
has been indicated that hepatic fatness plays a unique
important role in determination of type 2 diabetes [26,27].
Although WC is a widely recommended index for determining
central obesity and can be a strong determinant of diabetes,
there is no consensus on the standard measurement site for
this index. WC measured at the upper abdomen (just below
the lowest rib) has a stronger relation with VAT than WCmeasured at the lower abdomen (umbilicus or iliac crest) [28].
The VAT measured at the upper abdomen is additionally
associated more closely with obesity-related health risks than
VAT measured at the lower abdomen [29]. Furthermore, WC is
more related to abdominal sc fat than abdominal VAT [30], and
VAT more strongly correlates with insulin resistance than
abdominal sc fat [31]. In this study, ThC measured at the
prominence of the 7th–8th costochondral junctions (approxi-
mately 5 cm above the lowest rib) may be more related with
android fat/VAT than abdominal sc fat. Although ThC and WC
are highly correlated, they may reflect different aspects of
body fat (android/VAT versus abdominal sc fat). Further
studies should focus on the different relationships between
ThC and WC with abdominal sc fat and VAT.
We additionally found that THR and WHR, which are the
ratios that include information on upper/central trunk
measurements and hip size, had a stronger relationship with
diabetes than BMI and other anthropometric indices; the
effect of THR was slightly stronger than WHR (Table 3). WC and
HC have independent and opposite associations with diabetes
risk. A larger HC is inversely associated with cardiovascular
risk, including diabetes. The protective effect is most likely a
result of the increase in gluteofemoral fat and muscle mass
[25]. The combination of WC and HC in a ratio reflects not only
the size of body segments and local body fats but also the
pattern of fat distribution. Several studies have reported a
stronger correlation between diabetes and WHR than WC,
which may be a result of the integrative effects of both waist
and hip size [24,32,33]. THR can be considered as the ratio of
android fat, a harmful factor, to gluteofemoral (gynoid) fat, a
protective factor. Evidence showed that the ratio of android to
gynoid fat was associated with insulin resistance [34], and the
trunk-to-hip ratio was more related to baseline insulin and
QUICKI levels than abdominal-to-hip ratios [35]. Although THR
and WHR were relatively correlated (the Pearson’s correlation
coefficients were 0.62 in men and 0.73 in women) in the
current study, the correlation between diabetes and THR was
slightly stronger than that of WHR in all models, even after
adjusting for BMI. Interestingly, the correlation between
diabetes and THR remained within each tertile of WHR
(Fig. 1 and S1). Furthermore, the combination of a high BMI
and a high THR resulted in a higher risk of type 2 diabetes than
a combination of a high BMI and a high WHR, possibly because
of the stronger correlation between diabetes and android fat
versus abdominal sc fat. Taken together, body measurements
at the upper trunk, such as ThC and THR, provide more
accurate information on the risk of diabetes than BMI and
other anthropometric measurements, and they should be
considered in clinical and epidemiological studies.
This study has certain limitations. Although there may be
advantages of THR over BMI and WHR, THR is more difficult to
measure because it is not easy to identify the prominences of
the 7th–8th costochondral junctions in some circumstances,
such as serious obesity. The operators must be trained
thoroughly. We were unable to measure body fat composition
to examine the relationship between ThC and THR with
abdominal fat and VAT. In this study, WC was measured at the
umbilicus level that may cause measurement bias, particu-
larly in obese individuals. These findings originated from a
cross-sectional study and are unable to confirm any causal
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 0 4 ( 2 0 1 4 ) 2 7 3 – 2 8 0 279relationship. Because those who are forty or older are at a
higher risk of type 2 diabetes with a higher demand of diabetes
screening than those are at younger age, the present study
therefore focused on middle-aged and elderly Korean indivi-
duals. Thus, the results may not be generalizable to popula-
tions of other ages and races.
In conclusion, these data indicate that THR is associated
with type 2 diabetes beyond the effects of overall (assessed by
BMI) and central obesity (assessed by WHR) indicators in a
middle-aged and elderly Korean population. These findings
underline the importance of upper trunk measurements,
particularly ThC and THR, in epidemiological and clinical
studies.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Acknowledgements
This work was supported by the National Research Foundation
of Korea (NRF), and the grant was funded by the Korea Ministry
of Education, Science and Technology (MEST) [No.
20120009001(2006-2005173)]. This work was additionally sup-
ported by the Korea Centers for Disease Control and Preven-
tion [2009-E00454-00, 2010-E71001-00, and 2011-E71004-00].
C.S., N.H.C., and J.Y.K. designed and supervised the Korean
Health and Genome Epidemiology Study (KHGES), defined the
research theme, and edited the manuscript. D.D.P. designed
methods, analyzed the data, interpreted the results, and wrote
the manuscript. B.C.K. co-analyzed the data, interpreted the
results, and edited the manuscript. S.C. reviewed and edited
the manuscript and contributed to discussion.
r e f e r e n c e s
[1] WHO. The global burden of disease 2004 update. Geneva,
Switzerland: WHO; 2004.
[2] WHO Expert Consultation. Appropriate body-mass index
for Asian populations and its implications for policy and
intervention strategies. Lancet 2004;363(9403):157–63.
[3] Jensen MD. Role of body fat distribution and the metabolic
complications of obesity. J Clin Endocrinol Metab 2008;93(11
Suppl. 1):S57–63.
[4] Garg A. Regional adiposity and insulin resistance. J Clin
Endocrinol Metab 2004;89(9):4206–10.
[5] Vague J. The degree of masculine differentiation of
obesities: a factor determining predisposition to diabetes,
atherosclerosis, gout, and uric calculous disease. Am J Clin
Nutr 1956;4(1):20–34.
[6] Park SH, Choi SJ, Lee KS, Park HY. Waist circumference and
waist-to-height ratio as predictors of cardiovascular
disease risk in Korean adults. Circ J 2009;73(9):1643–50.
[7] de Koning L, Merchant AT, Pogue J, Anand SS. Waist
circumference and waist-to-hip ratio as predictors of
cardiovascular events: meta-regression analysis of
prospective studies. Eur Heart J 2007;28(7):850–6.
[8] Freedman DS, Rimm AA. The relation of body fat
distribution, as assessed by six girth measurements, todiabetes mellitus in women. Am J Public Health
1989;79(6):715–20.
[9] Preis SR, Massaro JM, Hoffmann U, D’Agostino Sr RB, Levy
D, Robins SJ, et al. Neck circumference as a novel measure
of cardiometabolic risk: the Framingham Heart study. J Clin
Endocrinol Metab 2010;95(8):3701–10.
[10] Ben-Noun LL, Laor A. Relationship between changes in
neck circumference and cardiovascular risk factors. Exp
Clin Cardiol 2006;11(1):14–20.
[11] Thanassoulis G, Massaro JM, Hoffmann U, Mahabadi AA,
Vasan RS, O’Donnell CJ, et al. Prevalence, distribution, and
risk factor correlates of high pericardial and intrathoracic
fat depots in the Framingham heart study. Circ Cardiovasc
Imaging 2010;3(5):559–66.
[12] Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad
NA, Patterson BW, et al. Intrahepatic fat, not visceral fat, is
linked with metabolic complications of obesity. Proc Natl
Acad Sci U S A 2009;106(36):15430–5.
[13] Rabkin SW. Epicardial fat: properties, function and
relationship to obesity. Obes Rev 2007;8(May (3)):
253–61.
[14] Kang SM, Yoon JW, Ahn HY, Kim SY, Lee KH, Shin H, et al.
Android fat depot is more closely associated with metabolic
syndrome than abdominal visceral fat in elderly people.
PLoS ONE 2011;6(11):e27694.
[15] Meisinger C, Do¨ring A, Thorand B, Heier M, Lo¨wel H. Body
fat distribution and risk of type 2 diabetes in the general
population: are there differences between men and
women? The MONICA/KORA Augsburg cohort study. Am J
Clin Nutr 2006;84(3):483–9.
[16] Yoo KY, Shin HR, Chang SH, Choi BY, Hong YC, Kim HD,
et al. Genomic epidemiology cohorts in Korea: present and
the future. Asian Pac J Cancer Prev 2005;6(3):238–43.
[17] Jang E, Kim JY, Lee H, Kim H, Baek Y, Lee S. A study on the
reliability of sasang constitutional body trunk
measurement. Evid Based Complement Alternat Med 2012.
http://dx.doi.org/10.1155/2012/604842.
[18] Shin C, Abbott RD, Lee H, Kim J, Kimm K. Prevalence and
correlates of orthostatic hypotension in middle-aged men
and women in Korea: the Korean Health and Genome
Study. J Hum Hypertens 2004;18(10):717–23.
[19] World Health Organization. Definition, diagnosis and
classification of diabetes mellitus and its complications:
report of a WHO Consultation. Part 1: diagnosis and
classification of diabetes mellitus. Geneva, Switzerland:
World Health Organization; 1999, Available at: http://
whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf
[accessed 05.12.12].
[20] Fluss R, Faraggi D, Reiser B. Estimation of the Youden index
and its associated cutoff point. Biom J 2005;47(4):458–72.
[21] Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB.
Comparison of abdominal adiposity and overall obesity in
predicting risk of type 2 diabetes among men. Am J Clin
Nutr 2005;81(3):555–63.
[22] Rexrode KM, Buring JE, Manson JE. Abdominal and total
adiposity and risk of coronary heart disease in men. Int J
Obes Relat Metab Disord 2001;25(7):1047–56.
[23] Taylor AE, Ebrahim S, Ben-Shlomo Y, Martin RM, Whincup
PH, Yarnell JW, et al. Comparison of the associations of
body mass index and measures of central adiposity and fat
mass with coronary heart disease, diabetes, and all-cause
mortality: a study using data from 4 UK cohorts. Am J Clin
Nutr 2010;91(3):547–56.
[24] Snijder MB, Zimmet PZ, Visser M, Dekker JM, Seidell JC,
Shaw JE. Independent and opposite associations of waist
and hip circumferences with diabetes, hypertension and
dyslipidemia: the AusDiab Study. Int J Obes Relat Metab
Disord 2004;28(March (3)):402–9.
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 0 4 ( 2 0 1 4 ) 2 7 3 – 2 8 0280[25] Heitmann BL, Lissner L. Hip Hip Hurrah! Hip size inversely
related to heart disease and total mortality. Obes Rev
2011;12(6):478–81.
[26] Stefan N, Kantartzis K, Machann J, Schick F, Thamer C,
Rittig K, et al. Identification and characterization of
metabolically benign obesity in humans. Arch Intern Med
2008;168(15):1609–16.
[27] Kantartzis K, Machann J, Schick F, Fritsche A, Ha¨ring HU,
Stefan N. The impact of liver fat vs visceral fat in
determining categories of prediabetes. Diabetologia
2010;53(5):882–9.
[28] Bosy-Westphal A, Booke CA, Blo¨cker T, Kossel E, Goele K,
Later W, et al. Measurement site for waist circumference
affects its accuracy as an index of visceral and abdominal
subcutaneous fat in a Caucasian population. J Nutr
2010;140(5):954–61.
[29] Shen W, Punyanitya M, Chen J, Gallagher D, Albu J, Pi-
Sunyer X, et al. Visceral adipose tissue: relationships
between single slice areas at different locations and
obesity-related health risks. Int J Obes (Lond)
2007;31(5):763–9.
[30] Oka R, Miura K, Sakurai M, Nakamura K, Yagi K, Miyamoto
S, et al. Comparison of waist circumference with body massindex for predicting abdominal adipose tissue. Diabetes Res
Clin Pract 2009;83(1):100–5.
[31] Preis SR, Massaro JM, Robins SJ, Hoffmann U, Vasan RS,
Irlbeck T, et al. Abdominal subcutaneous and visceral
adipose tissue and insulin resistance in the Framingham
heart study. Obesity (Silver Spring) 2010;18(11):2191–8.
[32] Lissner L, Bjorkelund C, Heitmann BL, Seidell JC, Bengtsson
C. Larger hip circumference independently predicts health
and longevity in a Swedish female cohort. Obes Res
2001;9:644–6.
[33] Seidell JC, Han TS, Feskens EJ, Lean ME. Narrow hips and
broad waist circumferences independently contribute to
increased risk of noninsulin-dependent diabetes mellitus. J
Intern Med 1997;242:401–6.
[34] Aucouturier J, Meyer M, Thivel D, Taillardat M, Duche´ P.
Effect of android to gynoid fat ratio on insulin resistance
in obese youth. Arch Pediatr Adolesc Med
2009;163(9):826–31.
[35] Penaforte FR, Japur CC, Diez-Garcia RW, Chiarello PG.
Upper trunk fat assessment and its relationship with
metabolic and biochemical variables and body fat in
polycystic ovary syndrome. J Hum Nutr Diet 2011;24(1):
39–46.
